Top Markets
#1 Black Phoenix Black Phoenix +820.83%
#2 Tutorial Tutorial +25.27%
#3 Beam Beam +25.04%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.53%
#5 MiL.k Alliance MiL.k Alliance +20.24%
#6 SAFEcoin SAFEcoin +18.55%
#7 Bless Bless +18.33%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.85%
#9 THORChain THORChain +15.63%
#10 Magma Finance Magma Finance +15.39%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rang in Aktien #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Aktienkurs
$29.86
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$2.48B
Veränderung (1 Tag)
4.92%
Veränderung (1 Jahr)
502.82%
Land
TW
Handel Lin BioScience, Inc. (6696)

Kategorie

Healthcare
Kursverlauf für Lin BioScience, Inc. (6696)
Höchster Schlusskurs: $26.88 am 2026-08-01

Niedrigster Schlusskurs: $1.30 am 2018-10-01
Kursverlauf der Aktie von Lin BioScience, Inc. von 2018 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.12 39.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.37%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $144.26 474.74%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.13 6.76%
CH